Agios Pharmaceuticals (AGIO) Shares Rose While Bb Biotech Ag Has Trimmed Its Stake by $1.71 Million; First Hawaiian Bank Has Lowered Hawaiian Electric Inds (HE) Position by $303,048 as Stock Price Declined

April 22, 2018 - By Henry Gaston

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Logo

First Hawaiian Bank decreased its stake in Hawaiian Electric Inds Inc (HE) by 30.43% based on its latest 2017Q4 regulatory filing with the SEC. First Hawaiian Bank sold 8,418 shares as the company’s stock declined 5.78% with the market. The institutional investor held 19,246 shares of the public utilities company at the end of 2017Q4, valued at $696,000, down from 27,664 at the end of the previous reported quarter. First Hawaiian Bank who had been investing in Hawaiian Electric Inds Inc for a number of months, seems to be less bullish one the $3.73 billion market cap company. It closed at $34.3 lastly. It is down 2.27% since April 22, 2017 and is uptrending. It has underperformed by 9.28% the S&P500.

Bb Biotech Ag decreased its stake in Agios Pharmaceuticals Inc. (AGIO) by 1.09% based on its latest 2017Q4 regulatory filing with the SEC. Bb Biotech Ag sold 30,000 shares as the company’s stock rose 38.11% while stock markets declined. The institutional investor held 2.72 million shares of the health care company at the end of 2017Q4, valued at $155.50 million, down from 2.75M at the end of the previous reported quarter. Bb Biotech Ag who had been investing in Agios Pharmaceuticals Inc. for a number of months, seems to be less bullish one the $4.96 billion market cap company. The stock decreased 2.08% or $1.84 during the last trading session, reaching $86.45. About 572,722 shares traded or 13.25% up from the average. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) has risen 41.40% since April 22, 2017 and is uptrending. It has outperformed by 29.85% the S&P500.

Since March 5, 2018, it had 0 insider purchases, and 1 sale for $308,570 activity.

First Hawaiian Bank, which manages about $789.21 million US Long portfolio, upped its stake in Vanguard High Dvd Yield Etf (VYM) by 6,609 shares to 70,698 shares, valued at $6.05 million in 2017Q4, according to the filing. It also increased its holding in Spdr S&P 500 Etf Trust (SPY) by 1,185 shares in the quarter, for a total of 51,699 shares, and has risen its stake in Ishares S&P Pref Stk Etf (PFF).

Analysts await Hawaiian Electric Industries, Inc. (NYSE:HE) to report earnings on May, 4. They expect $0.38 earnings per share, up 22.58% or $0.07 from last year’s $0.31 per share. HE’s profit will be $41.36M for 22.57 P/E if the $0.38 EPS becomes a reality. After $0.43 actual earnings per share reported by Hawaiian Electric Industries, Inc. for the previous quarter, Wall Street now forecasts -11.63% negative EPS growth.

Among 6 analysts covering Hawaiian Electric Industries (NYSE:HE), 0 have Buy rating, 3 Sell and 3 Hold. Therefore 0 are positive. Hawaiian Electric Industries had 9 analyst reports since August 14, 2015 according to SRatingsIntel. Zacks upgraded the shares of HE in report on Friday, August 14 to “Sell” rating. The stock of Hawaiian Electric Industries, Inc. (NYSE:HE) has “Market Perform” rating given on Friday, November 20 by Wells Fargo. JP Morgan maintained Hawaiian Electric Industries, Inc. (NYSE:HE) rating on Thursday, October 12. JP Morgan has “Neutral” rating and $34 target. The company was downgraded on Friday, August 28 by Zacks. The rating was maintained by JP Morgan with “Neutral” on Thursday, January 25. The rating was initiated by Bank of America with “Sell” on Tuesday, October 24. The stock has “Underweight” rating by Barclays Capital on Friday, March 18.

Investors sentiment increased to 1.47 in Q4 2017. Its up 0.19, from 1.28 in 2017Q3. It is positive, as 19 investors sold HE shares while 55 reduced holdings. 38 funds opened positions while 71 raised stakes. 51.32 million shares or 2.94% less from 52.87 million shares in 2017Q3 were reported. Amer Ser Inc reported 0.45% of its portfolio in Hawaiian Electric Industries, Inc. (NYSE:HE). Farmers Merchants Investments owns 22,067 shares or 0.06% of their US portfolio. Gsa Capital Prtnrs Llp invested in 5,583 shares or 0.01% of the stock. National Bank Of America Corp De holds 202,858 shares or 0% of its portfolio. Gateway Advisers reported 0.03% in Hawaiian Electric Industries, Inc. (NYSE:HE). D E Shaw & Co, New York-based fund reported 22,676 shares. Enterprise Financial Ser holds 0% of its portfolio in Hawaiian Electric Industries, Inc. (NYSE:HE) for 122 shares. Marshwinds Advisory owns 5,600 shares. Ls Inv Advisors Lc reported 0.01% stake. Aqr Capital Mgmt Limited Liability invested in 0.03% or 865,133 shares. Credit Suisse Ag invested 0% of its portfolio in Hawaiian Electric Industries, Inc. (NYSE:HE). Private Advisor Group Ltd Liability Company has invested 0.01% in Hawaiian Electric Industries, Inc. (NYSE:HE). Nordea Investment Ab reported 563,493 shares. Citigroup Inc holds 40,082 shares. Stifel has 21,849 shares for 0% of their portfolio.

Investors sentiment increased to 1.22 in Q4 2017. Its up 0.01, from 1.21 in 2017Q3. It improved, as 19 investors sold AGIO shares while 48 reduced holdings. 27 funds opened positions while 55 raised stakes. 45.70 million shares or 2.27% more from 44.69 million shares in 2017Q3 were reported. Spark Mngmt Ltd Co holds 0.04% of its portfolio in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) for 14,600 shares. Manufacturers Life Insurance Communications The accumulated 1,483 shares or 0% of the stock. Moreover, Tiaa Cref Inv Mngmt Lc has 0% invested in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) for 108,369 shares. Price T Rowe Assoc Md stated it has 1.82M shares or 0.02% of all its holdings. Moreover, Profund Advisors Ltd Limited Liability Company has 0.03% invested in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). Invesco Ltd reported 0.02% of its portfolio in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). Cubist Systematic Strategies Ltd Liability Co has invested 0% in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). Qs Invsts Ltd reported 2,800 shares. Lord Abbett And Limited Com stated it has 378,662 shares or 0.06% of all its holdings. Wellington Mgmt Ltd Liability Partnership stated it has 6.83 million shares or 0.09% of all its holdings. Bb Biotech Ag holds 4.38% or 2.72M shares in its portfolio. 2.81M were accumulated by International Invsts. Blackrock accumulated 0.01% or 2.81 million shares. Commercial Bank Of Mellon owns 174,029 shares for 0% of their portfolio. Federated Investors Pa invested in 9,093 shares or 0% of the stock.

Since January 10, 2018, it had 1 insider buy, and 20 sales for $17.04 million activity. On Thursday, February 1 Bowden Christopher sold $157,500 worth of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) or 2,000 shares. Biller Scott sold $195,000 worth of stock or 3,000 shares. Foster-Cheek Kaye I sold $557,396 worth of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) on Monday, March 19. Alenson Carman sold $161,250 worth of stock or 2,150 shares. Hoerter Steven L. also sold $1.87 million worth of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) shares. Scadden David also bought $16,688 worth of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) on Friday, March 16.

Analysts await Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) to report earnings on May, 4 before the open. They expect $-1.60 EPS, down 2.56% or $0.04 from last year’s $-1.56 per share. After $-1.81 actual EPS reported by Agios Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -11.60% EPS growth.

Bb Biotech Ag, which manages about $3.55B US Long portfolio, upped its stake in Five Prime Therapeutics Inc. (NASDAQ:FPRX) by 50,000 shares to 827,500 shares, valued at $18.14M in 2017Q4, according to the filing. It also increased its holding in Ionis Pharmaceuticals Inc. by 274,400 shares in the quarter, for a total of 8.14M shares, and has risen its stake in Esperion Therapeutics Inc. (NASDAQ:ESPR).

Among 16 analysts covering Agios Pharmaceuticals (NASDAQ:AGIO), 12 have Buy rating, 0 Sell and 4 Hold. Therefore 75% are positive. Agios Pharmaceuticals had 45 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) earned “Buy” rating by Cowen & Co on Tuesday, June 6. The firm has “Hold” rating given on Wednesday, August 5 by Roth Capital. The rating was maintained by Credit Suisse on Thursday, February 15 with “Buy”. On Friday, September 15 the stock rating was maintained by Needham with “Buy”. The company was maintained on Tuesday, October 3 by SunTrust. The firm has “Buy” rating given on Tuesday, August 1 by Cowen & Co. The firm has “Buy” rating given on Wednesday, November 1 by RBC Capital Markets. SunTrust maintained Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) on Sunday, November 19 with “Buy” rating. The firm earned “Buy” rating on Tuesday, August 8 by Oppenheimer. The rating was upgraded by JP Morgan on Monday, June 13 to “Overweight”.

Hawaiian Electric Industries, Inc. (NYSE:HE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: